IDF Europe

Public health community voices concerns over the moving of medicinal products and health technologies outside the health portfolio

IDF Europe has joined the public health community in Europe to send an open letter to Mr Juncker, President-elect of the European Commission, expressing astonishment and concern regarding his decision to move the competence for medicinal products and health technologies from the Commissioner in charge of Health to the Commissioner in charge of internal market and industry.

Oral health and diabetes: CED and IDF Europe celebrate European Oral Health Day

The Council of European Dentists (CED) and the International Diabetes Federation Europe (IDF Europe) are pleased to celebrate 12 September, the European Oral Health Day.

Diabetes Youth Advocates Europe

Diabetes Youth Advocates Europe - DYA Europe is a community of young people with diabetes from across Europe who have come together to leverage knowledge and experience to support people with type 1 diabetes.

ExPAND: The Policy Action Network on Diabetes

The Policy Action Network on Diabetes - ExPAND - is a policy and advocacy programme led by IDF Europe.

Established in 2012, ExPAND gathers together a group of National Parliamentarians, Members of the European Parliament, leading diabetes organizations and experts from across Europe. Their aim is to act as a strong pan-European forum to drive a new generation of policies to address the diabetes epidemic.

EASD Symposium: Patient Education in a Digital World

This year, IDF Europe will host a symposium on Patient Education in a Digital World on 14 September 2014 ahead of the 49th EASD Congress in Vienna.

Date: 
Sun, 09/14/2014

Deadline extended: applications for 2014 Prize in Diabetes, Young Researcher

This year, IDF Europe is awarding two IDF Europe Prizes in Diabetes to reward excellence, innovation and commitment in diabetes.

Parliamentarians across Europe unite to act on diabetes

Parliamentarians, leading diabetes organizations and experts from across Europe have joined forces to form the Policy Action Network on Diabetes (ExPAND) to drive a new generation of policies to address the diabetes epidemic.

Economics of chronic diseases: cost-effectiveness modelling and the burden of NCDs in Europe

Partners of the EConDA project have published their first paper presenting preliminary results of the study.

The Economics of Chronic Diseases (EConDA) project aims to establish the best possible methods of measuring cost-effectiveness as well as develop micro-simulation models apt at projecting future burden of chronic diseases, their costs and potential savings after implementation of cost-effective interventions.

Raising awareness of diabetes amongst future healthcare professionals

Combined use of medicines affecting the renin-angiotensin system (RAS) to be restricted

The European Medicines Agency (EMA) has endorsed restrictions on combining different classes of medicines that act on the renin-angiotensin system (RAS), a hormone system that controls blood pressure and the volume of fluids in the body.

Pages